(VELA) Study of BLU-222 in Advanced Solid Tumors
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Amgen
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
University of Oklahoma
Emory University
Innovent Biologics (Suzhou) Co. Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
NYU Langone Health